This is a literature report from UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND of 
PNEUMOCYSTIS PNEUMONIA, PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY DETERIORATED 
and PASSED AWAY in a 65-Year-old Female patient subsequent to unspecified immunoglobulin (IVIG) (coded to 
KIOVIG 100 MG/ML SOLUTION FOR INFUSION for reporting purposes) therapy.
The purpose of this article was to report a case of progressive multifocal leucoencephalopathy in a common 
variable immunodeficiency patient.
SUSPECT PRODUCT DETAILS: On an unreported date, the patient began treatment with unspecified IVIG 
(intravenously, 5 g/kg, 5 days, lot number not reported) for common variable immunodeficiency (CVID) and 
progressive multifocal leucoencephalopathy (considered off label indication). Action taken with unspecified IVIG 
was not applicable.
EVENT DETAILS: On an unreported date, the patient presented with progressive multifocal leucoencephalopathy 
(PML) also described as aphasia, progressive right sided weakness and cognitive impairment. CT and MRI head 
evidenced subcortical and periventricular white matter lesions, mainly within the frontal lobe. The patient was HIV 
negative. Lumbar puncture confirmed the presence of the John Cunningham (JC) virus. On an unreported date, the
patient developed PNEUMOCYSTIS PNEUMONIA (PCP) and PROGRESSIVE MULTIFOCAL 
LEUCOENCEPHALOPATHY DETERIORATED on MRI with new lesions in the cerebellum, parietal lobes, corpus 
callosum and mid brain. On an unreported date, the patient PASSED AWAY after a prolonged hospitalization. It 
was not reported if an autopsy was performed.
OUTCOME: PNEUMOCYSTIS PNEUMONIA: Not Reported, PROGRESSIVE MULTIFOCAL 
LEUCOENCEPHALOPATHY DETERIORATED: Not Reported, PASSED AWAY: Fatal (date of death: Not 
reported), Cause of death: Not reported.
MEDICAL HISTORY: COMMON VARIABLE IMMUNODEFICIENCY and PROGRESSIVE MULTIFOCAL 
LEUCOENCEPHALOPATHY.
CONCOMITANT THERAPY: Not Reported.
CAUSALITY ASSESSMENT: Not Reported.
Print Time: 07-JUN-2016 03:01 PM If a field is blank, there is no data for that field Page 91 of 549
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
KIOVIG 100 MG/ML SOLUTION FOR INFUSION was used off label for (progressive multifocal 
leucoencephalopathy).